|
The company has received a patent for a process for the preparation of 2-(Piperidin-4-YL)-1H-Benzo[D]Imidazole.
The pharmaco has also received a patent for a process for the direct synthesis of Fedratinib Intermediate.
Both the patents are received for the term of 20 years in accordance with the provisions of the Patents Act, 1970. The above mentioned patented processes have been indigenously developed at the R&D Centre of Ami Organics, stated the company.
With this, the company has been granted a total of nine patents.
AMI Organics is engaged in business of drugs intermediate chemicals and related activities.
The company reported a 24.82% decrease in consolidated net profit of Rs 16.75 crore despite of 9.24% rise in revenue from operations to Rs 166.44 crore in Q3 FY24 over Q3 FY23.
|